Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Evert van den Broek, Oscar Krijgsman, Daoud Sie, Marianne Tijssen, Sandra Mongera, Mark A. van de Wiel, Eric J. Th. Belt, Sjoerd H. den Uil, Herman Bril, Hein B.A.C. Stockmann, Bauke Ylstra, Beatriz Carvalho, Gerrit A. Meijer, Remond J.A. Fijneman
Published Oct 6, 2016 · Vol. 7, No. 45 · pp. 73876-73887
Juan Ji, Yufeng Qin, Rong Wang, Zhenyao Huang, Yan Zhang, Ran Zhou, Ling Song, Xiufeng Ling, Zhibin Hu, Dengshun Miao, Hongbing Shen, Yankai Xia, Xinru Wang, Chuncheng Lu
Published Oct 1, 2016 · Vol. 7, No. 48 · pp. 78532-78540
Marios Dimitriou, Petter S. Woll, Teresa Mortera-Blanco, Mohsen Karimi, David C. Wedge, Helen Doolittle, Iyadh Douagi, Elli Papaemmanuil, Sten Eirik W. Jacobsen, Eva Hellström-Lindberg
Published Sep 24, 2016 · Vol. 7, No. 45 · pp. 72685-72698